SmarterDx Raises $50M Series B Funding Round

SmarterDx Raises $50M Series B Funding Round

of New York City Smart DX has achieved a significant milestone with a total of $50 million in Series B funding, bringing its total funding to date to $71 million.

The funding round was led by Transformation Capital, with significant participation from Bessemer Venture Partners, Flair Capital Partners, and Floodgate Fund.

With this substantial investment, SmarterDx aims to accelerate its product innovation efforts, focusing on integrating new clinical and financial data and improving its proprietary algorithms. These enhancements will enable the identification of new revenue and quality opportunities for consumers, thereby benefiting hospitals and health systems.

Led by CEO Dr. Michael Gao, SmarterDx stands out as a clinical AI company specializing in revenue integrity and quality of care. Leveraging AI technology, SmarterDx comprehensively understands each patient's clinical journey, and helps hospitals accurately document patient information to close the revenue integrity “gap.” The company offers fast implementation, the ability to process over 30,000 data points per chart, and a risk-free return on investment.

Dr. Michael Gau emphasized the company's mission to empower clinical documentation integrity and coding teams to obtain a more accurate and complete picture of the patient. By enabling providers to focus on patient care instead of paperwork, SmarterDx is poised to make a significant impact in the healthcare industry.

About the Author

Leave a Reply